Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT02275468
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT02275468
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02275468. Randomized; double masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
- Condition
- Stage 3 Chronic Kidney Disease
- Condition
- Stage 4 Chronic Kidney Disease
- Intervention (Drug)
- Fu-zheng-qu-zhuo (FZQZ) oral liquid
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- Fangshan Hospital of Traditional Chinese Medicine,
- Collaborator
- Peking University First Hospital
Record details
- Record id
cardio:ct-nct02275468- Content hash
b20158b5603bb1ed1b0341d524d02afd82991827759673df6de75f6d1893803a